Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
A4234 TW-371 CitationTarget: Bcl-2|Bcl-xl|Mcl-1Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1 -
A4194 Obatoclax mesylate (GX15-070)1 CitationTarget: Bcl-2Summary: Potent Bcl-2 inhibitor -
A1922 Z-VDVAD-FMK3 CitationSummary: Caspase-2 inhibitor -
A8165 Q-VD(OMe)-OPh6 CitationTarget: CaspasesSummary: Pan-caspase inhibitor -
BA2722 TAK-243Summary: TAK-243 (MLN7243) is a first-of-its-kind, selective ubiquitin-activating enzyme, inhibitor. -
BA2740 3BDOSummary: 3BDO is a new type of activator. -
BA2766 MYCMI-6Summary: MYCMI-6 (NSC354961) is a potent and selective inhibitor of endogenous protein interactions. -
BA2823 SincalideSummary: Sincalide (Cholecystokininoctapeptide, CCK-8) is a fast-acting cholecystokinin (CCK)'s that is used intravenously during cholecystography. -
BA2988 BTM-3566Summary: BTM-3566 is an activator. -
A4419 Ac-LEHD-AFCSummary: Fluorogenic caspase substrate

